Skip to main content
MTRI logo

Mentari Therapeutics, Inc. (MTRI)

MTRINASDAQHealthcareBiotechnology

-Today:- (-)

Loading latest quote…

Market cap
-
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
-
Volume (live)
-
Avg. volume (3M)
-

Mentari Therapeutics (MTRI) Company Profile

Mentari Therapeutics is a Healthcare company in the Biotechnology industry, founded in 2025. Leadership, identifiers and contact details are below.

Mentari Therapeutics, Inc.
MTRINasdaq Stock MarketHealthcareBiotechnology

About Mentari Therapeutics

Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company’s products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone(916) 445-1254
Address
1625 North Market Blvd., Suite N112 Sacramento, California 95834 United States

Corporate Identifiers

CIK0001728328
CUSIP587157108
ISINUS5871571080
SIC2834

Leadership Team & Key Executives

Gregory J. Divis Jr.
Chief Executive Officer and Director
Keri Lantz CPA
Treasurer